Carmelo Monzon-Garcia
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Validation of BMP8A fibrosis score to identify patients with metabolic dysfunction-associated steatohepatitis with advanced liver fibrosis.
Journal: Biomarker research
Published: September 03, 2025
The inhibition of Il1β synthesis mediated by a novel pyridine-sulfonamide compound protects against the progression of metabolic dysfunction-associated steatotic liver disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 28, 2025
Normalization of Oxygen Levels Induces a Metabolic Reprogramming in Livers Exposed to Intermittent Hypoxia Mimicking Obstructive Sleep Apnea.
Journal: Antioxidants (Basel, Switzerland)
Published: May 31, 2025
BMP6 participates in the molecular mechanisms involved in APAP hepatotoxicity.
Journal: Archives of toxicology
Published: September 09, 2024
Protein kinase D2 modulates hepatic insulin sensitivity in male mice.
Journal: Molecular metabolism
Published: August 07, 2024
Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.
Journal: World journal of gastroenterology
Published: August 05, 2024
Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury.
Journal: Redox biology
Published: January 19, 2024
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
Journal: Journal of gastroenterology
Published: December 18, 2023
Beneficial effects of hepatic cyclooxygenase-2 expression against cholestatic injury after common bile duct ligation in mice.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 02, 2023
Hospital-based screening outperforms primary care screening as a means of achieving hepatitis C virus micro-elimination.
Journal: Infectious diseases now
Published: September 26, 2023
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.
Journal: United European gastroenterology journal
Published: July 17, 2023
Editorial: mitochondrial respiratory chain activity-a potential link with disease severity and treatment response in alcoholic hepatitis. Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: April 24, 2023
Last Updated: 09/26/2026